Thu, February 8, 2018
Wed, February 7, 2018
Tue, February 6, 2018
Mon, February 5, 2018
Fri, February 2, 2018
Thu, February 1, 2018
Wed, January 31, 2018
Tue, January 30, 2018
Mon, January 29, 2018
Fri, January 26, 2018
Thu, January 25, 2018

Geoff Meacham Maintained (VRTX) at Buy with Increased Target to $200 on, Feb 1st, 2018


  Copy link into your clipboard //stocks-investing.news-articles.net/content/201 .. ith-increased-target-to-200-on-feb-1st-2018.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Geoff Meacham of Barclays, Maintained "Vertex Pharmaceuticals Incorporated" (VRTX) at Buy with Increased Target from $180 to $200 on, Feb 1st, 2018.

Geoff, nor any peers, have made any analyst calls on VRTX in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30

Publication Contributing Sources